nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—Wound dehiscence—Carmustine—malignant glioma	0.084	0.129	CcSEcCtD
Fosaprepitant—Sensory disturbance—Temozolomide—malignant glioma	0.0302	0.0464	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—ROS1—malignant glioma	0.0244	0.0708	CbGpPWpGaD
Fosaprepitant—Febrile neutropenia—Carmustine—malignant glioma	0.0161	0.0247	CcSEcCtD
Fosaprepitant—Visual acuity reduced—Temozolomide—malignant glioma	0.0157	0.0242	CcSEcCtD
Fosaprepitant—Febrile neutropenia—Temozolomide—malignant glioma	0.0156	0.0239	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—BCAN—malignant glioma	0.0148	0.0429	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CCR4—malignant glioma	0.0141	0.0409	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—GDNF—malignant glioma	0.0119	0.0346	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—CXCR3—malignant glioma	0.0105	0.0304	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—GFAP—malignant glioma	0.0103	0.0297	CbGpPWpGaD
Fosaprepitant—Gait disturbance—Carmustine—malignant glioma	0.00992	0.0152	CcSEcCtD
Fosaprepitant—TACR1—Peptide GPCRs—BDKRB2—malignant glioma	0.00961	0.0278	CbGpPWpGaD
Fosaprepitant—Gait disturbance—Temozolomide—malignant glioma	0.00959	0.0147	CcSEcCtD
Fosaprepitant—Candida infection—Carmustine—malignant glioma	0.00924	0.0142	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—LGALS3—malignant glioma	0.00897	0.026	CbGpPWpGaD
Fosaprepitant—Candida infection—Temozolomide—malignant glioma	0.00893	0.0137	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00812	0.0235	CbGpPWpGaD
Fosaprepitant—Thrombophlebitis—Carmustine—malignant glioma	0.00812	0.0125	CcSEcCtD
Fosaprepitant—Thrombophlebitis—Temozolomide—malignant glioma	0.00785	0.0121	CcSEcCtD
Fosaprepitant—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00781	0.012	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.00749	0.0217	CbGpPWpGaD
Fosaprepitant—Hot flush—Temozolomide—malignant glioma	0.00726	0.0112	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00724	0.0209	CbGpPWpGaD
Fosaprepitant—Menopausal symptoms—Temozolomide—malignant glioma	0.0072	0.0111	CcSEcCtD
Fosaprepitant—Hyponatraemia—Carmustine—malignant glioma	0.00706	0.0108	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CCR4—malignant glioma	0.00665	0.0192	CbGpPWpGaD
Fosaprepitant—Hypokalaemia—Carmustine—malignant glioma	0.0064	0.00983	CcSEcCtD
Fosaprepitant—Muscular weakness—Carmustine—malignant glioma	0.0062	0.00952	CcSEcCtD
Fosaprepitant—Hypokalaemia—Temozolomide—malignant glioma	0.00618	0.0095	CcSEcCtD
Fosaprepitant—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00612	0.0094	CcSEcCtD
Fosaprepitant—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00612	0.0094	CcSEcCtD
Fosaprepitant—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00599	0.0092	CcSEcCtD
Fosaprepitant—Muscular weakness—Temozolomide—malignant glioma	0.00599	0.0092	CcSEcCtD
Fosaprepitant—Abdominal distension—Temozolomide—malignant glioma	0.00591	0.00908	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—GJA1—malignant glioma	0.00578	0.0167	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.00563	0.0163	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.00563	0.0163	CbGpPWpGaD
Fosaprepitant—Dysuria—Temozolomide—malignant glioma	0.00549	0.00843	CcSEcCtD
Fosaprepitant—Pollakiuria—Temozolomide—malignant glioma	0.00542	0.00833	CcSEcCtD
Fosaprepitant—Photosensitivity reaction—Temozolomide—malignant glioma	0.00536	0.00823	CcSEcCtD
Fosaprepitant—Weight decreased—Temozolomide—malignant glioma	0.00531	0.00816	CcSEcCtD
Fosaprepitant—Stomatitis—Carmustine—malignant glioma	0.00528	0.00811	CcSEcCtD
Fosaprepitant—Urinary tract infection—Carmustine—malignant glioma	0.00526	0.00809	CcSEcCtD
Fosaprepitant—Infestation—Temozolomide—malignant glioma	0.00523	0.00804	CcSEcCtD
Fosaprepitant—Infestation NOS—Temozolomide—malignant glioma	0.00523	0.00804	CcSEcCtD
Fosaprepitant—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00519	0.00797	CcSEcCtD
Fosaprepitant—Stomatitis—Temozolomide—malignant glioma	0.0051	0.00784	CcSEcCtD
Fosaprepitant—Urinary tract infection—Temozolomide—malignant glioma	0.00509	0.00782	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCR3—malignant glioma	0.00494	0.0143	CbGpPWpGaD
Fosaprepitant—Hypoaesthesia—Carmustine—malignant glioma	0.00484	0.00743	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Carmustine—malignant glioma	0.00478	0.00734	CcSEcCtD
Fosaprepitant—Hypoaesthesia—Temozolomide—malignant glioma	0.00467	0.00718	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Temozolomide—malignant glioma	0.00464	0.00713	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00463	0.0134	CbGpPWpGaD
Fosaprepitant—Connective tissue disorder—Temozolomide—malignant glioma	0.00462	0.00709	CcSEcCtD
Fosaprepitant—Urethral disorder—Temozolomide—malignant glioma	0.00461	0.00708	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—BDKRB2—malignant glioma	0.00458	0.0133	CbGpPWpGaD
Fosaprepitant—Eye disorder—Carmustine—malignant glioma	0.00454	0.00698	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—BDKRB2—malignant glioma	0.00452	0.0131	CbGpPWpGaD
Fosaprepitant—Flushing—Carmustine—malignant glioma	0.00451	0.00693	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00446	0.0129	CbGpPWpGaD
Fosaprepitant—Erythema multiforme—Temozolomide—malignant glioma	0.00444	0.00682	CcSEcCtD
Fosaprepitant—Eye disorder—Temozolomide—malignant glioma	0.00439	0.00675	CcSEcCtD
Fosaprepitant—Tinnitus—Temozolomide—malignant glioma	0.00438	0.00673	CcSEcCtD
Fosaprepitant—Flushing—Temozolomide—malignant glioma	0.00436	0.0067	CcSEcCtD
Fosaprepitant—Cardiac disorder—Temozolomide—malignant glioma	0.00436	0.0067	CcSEcCtD
Fosaprepitant—Angiopathy—Temozolomide—malignant glioma	0.00426	0.00655	CcSEcCtD
Fosaprepitant—Mental disorder—Carmustine—malignant glioma	0.00426	0.00654	CcSEcCtD
Fosaprepitant—Immune system disorder—Temozolomide—malignant glioma	0.00424	0.00652	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Temozolomide—malignant glioma	0.00423	0.00651	CcSEcCtD
Fosaprepitant—Erythema—Carmustine—malignant glioma	0.00423	0.0065	CcSEcCtD
Fosaprepitant—Malnutrition—Carmustine—malignant glioma	0.00423	0.0065	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—KNG1—malignant glioma	0.00416	0.0121	CbGpPWpGaD
Fosaprepitant—Mental disorder—Temozolomide—malignant glioma	0.00412	0.00632	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—KNG1—malignant glioma	0.00411	0.0119	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—malignant glioma	0.00409	0.0119	CbGpPWpGaD
Fosaprepitant—Erythema—Temozolomide—malignant glioma	0.00409	0.00628	CcSEcCtD
Fosaprepitant—Malnutrition—Temozolomide—malignant glioma	0.00409	0.00628	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00403	0.0117	CbGpPWpGaD
Fosaprepitant—Dysgeusia—Temozolomide—malignant glioma	0.00401	0.00615	CcSEcCtD
Fosaprepitant—Anaemia—Carmustine—malignant glioma	0.00391	0.00601	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Temozolomide—malignant glioma	0.00379	0.00583	CcSEcCtD
Fosaprepitant—Anaemia—Temozolomide—malignant glioma	0.00378	0.00581	CcSEcCtD
Fosaprepitant—Angioedema—Temozolomide—malignant glioma	0.00374	0.00574	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—malignant glioma	0.00372	0.0108	CbGpPWpGaD
Fosaprepitant—Malaise—Temozolomide—malignant glioma	0.00369	0.00567	CcSEcCtD
Fosaprepitant—Hypertension—Carmustine—malignant glioma	0.00365	0.00561	CcSEcCtD
Fosaprepitant—Palpitations—Temozolomide—malignant glioma	0.00361	0.00555	CcSEcCtD
Fosaprepitant—Chest pain—Carmustine—malignant glioma	0.0036	0.00554	CcSEcCtD
Fosaprepitant—Anxiety—Carmustine—malignant glioma	0.00359	0.00552	CcSEcCtD
Fosaprepitant—Cough—Temozolomide—malignant glioma	0.00357	0.00548	CcSEcCtD
Fosaprepitant—Hypertension—Temozolomide—malignant glioma	0.00353	0.00543	CcSEcCtD
Fosaprepitant—Anxiety—Temozolomide—malignant glioma	0.00347	0.00533	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00346	0.00531	CcSEcCtD
Fosaprepitant—Oedema—Carmustine—malignant glioma	0.00345	0.00531	CcSEcCtD
Fosaprepitant—Discomfort—Temozolomide—malignant glioma	0.00344	0.00529	CcSEcCtD
Fosaprepitant—Infection—Carmustine—malignant glioma	0.00343	0.00527	CcSEcCtD
Fosaprepitant—Dry mouth—Temozolomide—malignant glioma	0.00341	0.00523	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—CCR4—malignant glioma	0.0034	0.00983	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.00338	0.00978	CbGpPWpGaD
Fosaprepitant—Oedema—Temozolomide—malignant glioma	0.00334	0.00513	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Temozolomide—malignant glioma	0.00334	0.00513	CcSEcCtD
Fosaprepitant—Infection—Temozolomide—malignant glioma	0.00332	0.00509	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00331	0.00959	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.0033	0.00955	CbGpPWpGaD
Fosaprepitant—Nervous system disorder—Temozolomide—malignant glioma	0.00327	0.00503	CcSEcCtD
Fosaprepitant—Skin disorder—Temozolomide—malignant glioma	0.00324	0.00498	CcSEcCtD
Fosaprepitant—Hypotension—Carmustine—malignant glioma	0.00323	0.00496	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Temozolomide—malignant glioma	0.00323	0.00496	CcSEcCtD
Fosaprepitant—Insomnia—Carmustine—malignant glioma	0.00312	0.0048	CcSEcCtD
Fosaprepitant—Dyspnoea—Carmustine—malignant glioma	0.00308	0.00473	CcSEcCtD
Fosaprepitant—Somnolence—Carmustine—malignant glioma	0.00307	0.00472	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00303	0.00878	CbGpPWpGaD
Fosaprepitant—Insomnia—Temozolomide—malignant glioma	0.00302	0.00464	CcSEcCtD
Fosaprepitant—Decreased appetite—Carmustine—malignant glioma	0.003	0.00461	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Carmustine—malignant glioma	0.00298	0.00458	CcSEcCtD
Fosaprepitant—Dyspnoea—Temozolomide—malignant glioma	0.00298	0.00457	CcSEcCtD
Fosaprepitant—Somnolence—Temozolomide—malignant glioma	0.00297	0.00456	CcSEcCtD
Fosaprepitant—Constipation—Carmustine—malignant glioma	0.00295	0.00454	CcSEcCtD
Fosaprepitant—Pain—Carmustine—malignant glioma	0.00295	0.00454	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—IFNG—malignant glioma	0.00295	0.00853	CbGpPWpGaD
Fosaprepitant—Dyspepsia—Temozolomide—malignant glioma	0.00294	0.00451	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—LATS2—malignant glioma	0.0029	0.0084	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Temozolomide—malignant glioma	0.0029	0.00446	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00288	0.00443	CcSEcCtD
Fosaprepitant—Fatigue—Temozolomide—malignant glioma	0.00288	0.00442	CcSEcCtD
Fosaprepitant—Pain—Temozolomide—malignant glioma	0.00285	0.00439	CcSEcCtD
Fosaprepitant—Constipation—Temozolomide—malignant glioma	0.00285	0.00439	CcSEcCtD
Fosaprepitant—Feeling abnormal—Carmustine—malignant glioma	0.00285	0.00437	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—PTGS2—malignant glioma	0.00283	0.00818	CbGpPWpGaD
Fosaprepitant—Gastrointestinal pain—Carmustine—malignant glioma	0.00282	0.00434	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00276	0.00798	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Temozolomide—malignant glioma	0.00275	0.00423	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—CXCL8—malignant glioma	0.00274	0.00794	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Carmustine—malignant glioma	0.00273	0.0042	CcSEcCtD
Fosaprepitant—Body temperature increased—Carmustine—malignant glioma	0.00273	0.0042	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Temozolomide—malignant glioma	0.00273	0.00419	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—F2—malignant glioma	0.00269	0.00779	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—F2—malignant glioma	0.00266	0.00769	CbGpPWpGaD
Fosaprepitant—Urticaria—Temozolomide—malignant glioma	0.00265	0.00407	CcSEcCtD
Fosaprepitant—Abdominal pain—Temozolomide—malignant glioma	0.00264	0.00405	CcSEcCtD
Fosaprepitant—Body temperature increased—Temozolomide—malignant glioma	0.00264	0.00405	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1B—malignant glioma	0.00263	0.00761	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CASP3—malignant glioma	0.00262	0.0076	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL2—malignant glioma	0.00262	0.00758	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Carmustine—malignant glioma	0.00254	0.00391	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—CXCR3—malignant glioma	0.00252	0.00731	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MMP9—malignant glioma	0.00248	0.00718	CbGpPWpGaD
Fosaprepitant—Asthenia—Carmustine—malignant glioma	0.00248	0.00381	CcSEcCtD
Fosaprepitant—Hypersensitivity—Temozolomide—malignant glioma	0.00246	0.00378	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—malignant glioma	0.00241	0.00697	CbGpPWpGaD
Fosaprepitant—Asthenia—Temozolomide—malignant glioma	0.00239	0.00368	CcSEcCtD
Fosaprepitant—Diarrhoea—Carmustine—malignant glioma	0.00236	0.00363	CcSEcCtD
Fosaprepitant—Pruritus—Temozolomide—malignant glioma	0.00236	0.00363	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—BDKRB2—malignant glioma	0.00231	0.00668	CbGpPWpGaD
Fosaprepitant—Dizziness—Carmustine—malignant glioma	0.00228	0.00351	CcSEcCtD
Fosaprepitant—Diarrhoea—Temozolomide—malignant glioma	0.00228	0.00351	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.00226	0.00655	CbGpPWpGaD
Fosaprepitant—Dizziness—Temozolomide—malignant glioma	0.00221	0.00339	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—LATS1—malignant glioma	0.0022	0.00637	CbGpPWpGaD
Fosaprepitant—Vomiting—Carmustine—malignant glioma	0.0022	0.00337	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.00219	0.00635	CbGpPWpGaD
Fosaprepitant—Rash—Carmustine—malignant glioma	0.00218	0.00335	CcSEcCtD
Fosaprepitant—Dermatitis—Carmustine—malignant glioma	0.00218	0.00334	CcSEcCtD
Fosaprepitant—Headache—Carmustine—malignant glioma	0.00216	0.00332	CcSEcCtD
Fosaprepitant—Vomiting—Temozolomide—malignant glioma	0.00212	0.00326	CcSEcCtD
Fosaprepitant—Rash—Temozolomide—malignant glioma	0.0021	0.00323	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.0021	0.00609	CbGpPWpGaD
Fosaprepitant—Dermatitis—Temozolomide—malignant glioma	0.0021	0.00323	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—KNG1—malignant glioma	0.0021	0.00608	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.0021	0.00608	CbGpPWpGaD
Fosaprepitant—Headache—Temozolomide—malignant glioma	0.00209	0.00321	CcSEcCtD
Fosaprepitant—Nausea—Carmustine—malignant glioma	0.00205	0.00315	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—MYC—malignant glioma	0.00205	0.00593	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—EGFR—malignant glioma	0.002	0.0058	CbGpPWpGaD
Fosaprepitant—Nausea—Temozolomide—malignant glioma	0.00198	0.00305	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—CCR4—malignant glioma	0.00192	0.00556	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—malignant glioma	0.00191	0.00552	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—CXCL8—malignant glioma	0.00187	0.00542	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	0.00181	0.00523	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00178	0.00516	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00178	0.00516	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CCR4—malignant glioma	0.00174	0.00505	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—TP53—malignant glioma	0.00168	0.00487	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.00153	0.00442	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MDK—malignant glioma	0.00149	0.0043	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCR3—malignant glioma	0.00143	0.00413	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DTX1—malignant glioma	0.00142	0.0041	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—F2—malignant glioma	0.00136	0.00393	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—BDKRB2—malignant glioma	0.0013	0.00378	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCR3—malignant glioma	0.0013	0.00375	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00126	0.00364	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	0.00124	0.00359	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—PIK3CA—malignant glioma	0.0012	0.00348	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—KNG1—malignant glioma	0.00119	0.00344	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—BDKRB2—malignant glioma	0.00118	0.00343	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	0.00117	0.00339	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SUFU—malignant glioma	0.00113	0.00326	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HEY2—malignant glioma	0.00111	0.00322	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GFAP—malignant glioma	0.00109	0.00314	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—KNG1—malignant glioma	0.00108	0.00312	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	0.00108	0.00312	CbGpPWpGaD
Fosaprepitant—TACR1—brainstem—malignant glioma	0.00107	0.293	CbGeAlD
Fosaprepitant—TACR1—Signaling Pathways—SPHK1—malignant glioma	0.00105	0.00304	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HEY1—malignant glioma	0.00103	0.00298	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CCR4—malignant glioma	0.00103	0.00298	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HIST1H3B—malignant glioma	0.001	0.0029	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—CXCL8—malignant glioma	0.000957	0.00277	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—MMP3—malignant glioma	0.000955	0.00276	CbGpPWpGaD
Fosaprepitant—TACR1—telencephalon—malignant glioma	0.000946	0.26	CbGeAlD
Fosaprepitant—TACR1—Signaling Pathways—JAG2—malignant glioma	0.000913	0.00264	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—H3F3A—malignant glioma	0.000773	0.00224	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—F2—malignant glioma	0.000767	0.00222	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCR3—malignant glioma	0.000765	0.00221	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—YWHAE—malignant glioma	0.000744	0.00215	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NTRK2—malignant glioma	0.000744	0.00215	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FLT1—malignant glioma	0.000741	0.00215	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—DUSP6—malignant glioma	0.000738	0.00214	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000734	0.00213	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—JAG1—malignant glioma	0.000728	0.00211	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOTCH3—malignant glioma	0.000725	0.0021	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FBXW7—malignant glioma	0.000714	0.00207	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—BDKRB2—malignant glioma	0.0007	0.00203	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—F2—malignant glioma	0.000697	0.00202	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AKT2—malignant glioma	0.000672	0.00194	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PIK3CG—malignant glioma	0.000667	0.00193	CbGpPWpGaD
Fosaprepitant—TACR1—spinal cord—malignant glioma	0.000663	0.182	CbGeAlD
Fosaprepitant—TACR1—Signaling by GPCR—PTPN11—malignant glioma	0.000655	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOTCH2—malignant glioma	0.000651	0.00188	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000645	0.00187	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KNG1—malignant glioma	0.000637	0.00184	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AKT2—malignant glioma	0.00061	0.00177	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NTRK1—malignant glioma	0.000607	0.00176	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PIK3CD—malignant glioma	0.000586	0.0017	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP3—malignant glioma	0.000564	0.00163	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PIK3CB—malignant glioma	0.000563	0.00163	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CDKN2B—malignant glioma	0.000559	0.00162	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTK2—malignant glioma	0.000543	0.00157	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—CXCL8—malignant glioma	0.000541	0.00156	CbGpPWpGaD
Fosaprepitant—TACR1—central nervous system—malignant glioma	0.000538	0.148	CbGeAlD
Fosaprepitant—TACR1—Signaling Pathways—HES1—malignant glioma	0.000533	0.00154	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NCOR1—malignant glioma	0.00053	0.00154	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—RAF1—malignant glioma	0.000523	0.00151	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—IL2—malignant glioma	0.000517	0.0015	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000511	0.00148	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDGFRA—malignant glioma	0.000508	0.00147	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SPP1—malignant glioma	0.000493	0.00143	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—CXCL8—malignant glioma	0.000491	0.00142	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—IL2—malignant glioma	0.000469	0.00136	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TERT—malignant glioma	0.000467	0.00135	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PDGFB—malignant glioma	0.000456	0.00132	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGFR1—malignant glioma	0.000454	0.00131	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—HIF1A—malignant glioma	0.000447	0.00129	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CAV1—malignant glioma	0.000432	0.00125	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KDR—malignant glioma	0.000428	0.00124	CbGpPWpGaD
Fosaprepitant—TACR1—brain—malignant glioma	0.000427	0.117	CbGeAlD
Fosaprepitant—TACR1—Signaling Pathways—F2—malignant glioma	0.000412	0.00119	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FN1—malignant glioma	0.000412	0.00119	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—BAD—malignant glioma	0.000407	0.00118	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOTCH1—malignant glioma	0.000403	0.00117	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CD80—malignant glioma	0.000395	0.00114	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PIK3CG—malignant glioma	0.000394	0.00114	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APC—malignant glioma	0.000394	0.00114	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EGF—malignant glioma	0.000389	0.00113	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTPN11—malignant glioma	0.000387	0.00112	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—BRAF—malignant glioma	0.00037	0.00107	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AKT2—malignant glioma	0.00036	0.00104	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EGFR—malignant glioma	0.000359	0.00104	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PIK3CD—malignant glioma	0.000346	0.001	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000343	0.000993	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—KRAS—malignant glioma	0.000339	0.000981	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FGF2—malignant glioma	0.000332	0.00096	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PIK3CA—malignant glioma	0.000311	0.000901	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MDM2—malignant glioma	0.00031	0.000898	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—RAF1—malignant glioma	0.000309	0.000895	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—ERBB2—malignant glioma	0.000306	0.000885	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PIK3CB—malignant glioma	0.000302	0.000874	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CXCL8—malignant glioma	0.00029	0.000839	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AKT1—malignant glioma	0.00028	0.000811	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CASP3—malignant glioma	0.000278	0.000803	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—IL2—malignant glioma	0.000277	0.000802	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—malignant glioma	0.000262	0.000759	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PTEN—malignant glioma	0.000261	0.000755	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AKT1—malignant glioma	0.000254	0.000736	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VEGFA—malignant glioma	0.000236	0.000682	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—STAT3—malignant glioma	0.000233	0.000675	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MYC—malignant glioma	0.000217	0.000627	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EGFR—malignant glioma	0.000212	0.000614	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—KRAS—malignant glioma	0.0002	0.00058	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—PIK3CA—malignant glioma	0.000184	0.000533	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TP53—malignant glioma	0.000178	0.000515	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AKT1—malignant glioma	0.00015	0.000435	CbGpPWpGaD
